Neurotransmitter Agents
Neurotransmitter Transport Proteins
Plasma Membrane Neurotransmitter Transport Proteins
Receptors, Neurotransmitter
Cell surface receptors that bind signalling molecules released by neurons and convert these signals into intracellular changes influencing the behavior of cells. Neurotransmitter is used here in its most general sense, including not only messengers that act to regulate ion channels, but also those which act on second messenger systems and those which may act at a distance from their release sites. Included are receptors for neuromodulators, neuroregulators, neuromediators, and neurohumors, whether or not located at synapses.
Synaptic Vesicles
Membrane-bound compartments which contain transmitter molecules. Synaptic vesicles are concentrated at presynaptic terminals. They actively sequester transmitter molecules from the cytoplasm. In at least some synapses, transmitter release occurs by fusion of these vesicles with the presynaptic membrane, followed by exocytosis of their contents.
Synaptic Transmission
The communication from a NEURON to a target (neuron, muscle, or secretory cell) across a SYNAPSE. In chemical synaptic transmission, the presynaptic neuron releases a NEUROTRANSMITTER that diffuses across the synaptic cleft and binds to specific synaptic receptors, activating them. The activated receptors modulate specific ion channels and/or second-messenger systems in the postsynaptic cell. In electrical synaptic transmission, electrical signals are communicated as an ionic current flow across ELECTRICAL SYNAPSES.
Glutamic Acid
Neurons
Presynaptic Terminals
The distal terminations of axons which are specialized for the release of neurotransmitters. Also included are varicosities along the course of axons which have similar specializations and also release transmitters. Presynaptic terminals in both the central and peripheral nervous systems are included.
Synapses
Specialized junctions at which a neuron communicates with a target cell. At classical synapses, a neuron's presynaptic terminal releases a chemical transmitter stored in synaptic vesicles which diffuses across a narrow synaptic cleft and activates receptors on the postsynaptic membrane of the target cell. The target may be a dendrite, cell body, or axon of another neuron, or a specialized region of a muscle or secretory cell. Neurons may also communicate via direct electrical coupling with ELECTRICAL SYNAPSES. Several other non-synaptic chemical or electric signal transmitting processes occur via extracellular mediated interactions.
Serotonin
A biochemical messenger and regulator, synthesized from the essential amino acid L-TRYPTOPHAN. In humans it is found primarily in the central nervous system, gastrointestinal tract, and blood platelets. Serotonin mediates several important physiological functions including neurotransmission, gastrointestinal motility, hemostasis, and cardiovascular integrity. Multiple receptor families (RECEPTORS, SEROTONIN) explain the broad physiological actions and distribution of this biochemical mediator.
Dopamine
One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action.
Synapsins
A family of synaptic vesicle-associated proteins involved in the short-term regulation of NEUROTRANSMITTER release. Synapsin I, the predominant member of this family, links SYNAPTIC VESICLES to ACTIN FILAMENTS in the presynaptic nerve terminal. These interactions are modulated by the reversible PHOSPHORYLATION of synapsin I through various signal transduction pathways. The protein is also a substrate for cAMP- and CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES. It is believed that these functional properties are also shared by synapsin II.
Exocytosis
Brain
The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM.
GABA Plasma Membrane Transport Proteins
A family of plasma membrane neurotransmitter transporter proteins that regulates extracellular levels of the inhibitory neurotransmitter GAMMA-AMINOBUTYRIC ACID. They differ from GABA RECEPTORS, which signal cellular responses to GAMMA-AMINOBUTYRIC ACID. They control GABA reuptake into PRESYNAPTIC TERMINALS in the CENTRAL NERVOUS SYSTEM through high-affinity sodium-dependent transport.
Synaptotagmin I
Calcium
A basic element found in nearly all organized tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes.
Synaptosomal-Associated Protein 25
Acetylcholine
Synaptosomes
Synaptotagmins
Choline O-Acetyltransferase
Hippocampus
A curved elevation of GRAY MATTER extending the entire length of the floor of the TEMPORAL HORN of the LATERAL VENTRICLE (see also TEMPORAL LOBE). The hippocampus proper, subiculum, and DENTATE GYRUS constitute the hippocampal formation. Sometimes authors include the ENTORHINAL CORTEX in the hippocampal formation.
Norepinephrine
Precursor of epinephrine that is secreted by the adrenal medulla and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers and of the diffuse projection system in the brain arising from the locus ceruleus. It is also found in plants and is used pharmacologically as a sympathomimetic.
Rats, Sprague-Dawley
Excitatory Postsynaptic Potentials
Patch-Clamp Techniques
An electrophysiologic technique for studying cells, cell membranes, and occasionally isolated organelles. All patch-clamp methods rely on a very high-resistance seal between a micropipette and a membrane; the seal is usually attained by gentle suction. The four most common variants include on-cell patch, inside-out patch, outside-out patch, and whole-cell clamp. Patch-clamp methods are commonly used to voltage clamp, that is control the voltage across the membrane and measure current flow, but current-clamp methods, in which the current is controlled and the voltage is measured, are also used.
Receptors, GABA
Cell-surface proteins that bind GAMMA-AMINOBUTYRIC ACID with high affinity and trigger changes that influence the behavior of cells. GABA-A receptors control chloride channels formed by the receptor complex itself. They are blocked by bicuculline and usually have modulatory sites sensitive to benzodiazepines and barbiturates. GABA-B receptors act through G-proteins on several effector systems, are insensitive to bicuculline, and have a high affinity for L-baclofen.
Receptors, Glutamate
Cell-surface proteins that bind glutamate and trigger changes which influence the behavior of cells. Glutamate receptors include ionotropic receptors (AMPA, kainate, and N-methyl-D-aspartate receptors), which directly control ion channels, and metabotropic receptors which act through second messenger systems. Glutamate receptors are the most common mediators of fast excitatory synaptic transmission in the central nervous system. They have also been implicated in the mechanisms of memory and of many diseases.
Neurotransmitter Uptake Inhibitors
Drugs that inhibit the transport of neurotransmitters into axon terminals or into storage vesicles within terminals. For many transmitters, uptake determines the time course of transmitter action so inhibiting uptake prolongs the activity of the transmitter. Blocking uptake may also deplete available transmitter stores. Many clinically important drugs are uptake inhibitors although the indirect reactions of the brain rather than the acute block of uptake itself is often responsible for the therapeutic effects.
SNARE Proteins
A superfamily of small proteins which are involved in the MEMBRANE FUSION events, intracellular protein trafficking and secretory processes. They share a homologous SNARE motif. The SNARE proteins are divided into subfamilies: QA-SNARES; QB-SNARES; QC-SNARES; and R-SNARES. The formation of a SNARE complex (composed of one each of the four different types SNARE domains (Qa, Qb, Qc, and R)) mediates MEMBRANE FUSION. Following membrane fusion SNARE complexes are dissociated by the NSFs (N-ETHYLMALEIMIDE-SENSITIVE FACTORS), in conjunction with SOLUBLE NSF ATTACHMENT PROTEIN, i.e., SNAPs (no relation to SNAP 25.)
Vesicular Glutamate Transport Proteins
A family of vesicular neurotransmitter transporter proteins that were originally characterized as sodium dependent inorganic phosphate cotransporters. Vesicular glutamate transport proteins sequester the excitatory neurotransmitter GLUTAMATE from the CYTOPLASM into SECRETORY VESICLES in exchange for lumenal PROTONS.
Electrophysiology
Glycine
Calcium Channels, N-Type
Vesicular Neurotransmitter Transport Proteins
Neuropeptides
Spider Venoms
R-SNARE Proteins
SNARE proteins where the central amino acid residue of the SNARE motif is an ARGININE. They are classified separately from the Q-SNARE PROTEINS where the central amino acid residue of the SNARE motif is a GLUTAMINE. This subfamily contains the vesicle associated membrane proteins (VAMPs) based on similarity to the prototype for the R-SNAREs, VAMP2 (synaptobrevin 2).
Syntaxin 1
Synaptotagmin II
A vesicular transport protein that was originally characterized as an inositol polyphosphate binding protein. Synaptotagmin II helps regulate EXOCYTOSIS of SYNAPTIC VESICLES and appears to serve as a calcium sensor to trigger NEUROTRANSMITTER release. It also acts as a nerve cell receptor for certain BOTULINUM TOXINS.
Brain Chemistry
Calcium Channels
Voltage-dependent cell membrane glycoproteins selectively permeable to calcium ions. They are categorized as L-, T-, N-, P-, Q-, and R-types based on the activation and inactivation kinetics, ion specificity, and sensitivity to drugs and toxins. The L- and T-types are present throughout the cardiovascular and central nervous systems and the N-, P-, Q-, & R-types are located in neuronal tissue.
Receptors, GABA-B
Glycine Plasma Membrane Transport Proteins
A family of sodium chloride-dependent neurotransmitter symporters that transport the amino acid GLYCINE. They differ from GLYCINE RECEPTORS, which signal cellular responses to GLYCINE. They are located primarily on the PLASMA MEMBRANE of NEURONS; GLIAL CELLS; EPITHELIAL CELLS; and RED BLOOD CELLS where they remove inhibitory neurotransmitter glycine from the EXTRACELLULAR SPACE.
Neuronal Plasticity
Excitatory Amino Acid Antagonists
Synaptic Membranes
Membrane Potentials
The voltage differences across a membrane. For cellular membranes they are computed by subtracting the voltage measured outside the membrane from the voltage measured inside the membrane. They result from differences of inside versus outside concentration of potassium, sodium, chloride, and other ions across cells' or ORGANELLES membranes. For excitable cells, the resting membrane potentials range between -30 and -100 millivolts. Physical, chemical, or electrical stimuli can make a membrane potential more negative (hyperpolarization), or less negative (depolarization).
Cells, Cultured
Receptors, GABA-A
Nerve Endings
Branch-like terminations of NERVE FIBERS, sensory or motor NEURONS. Endings of sensory neurons are the beginnings of afferent pathway to the CENTRAL NERVOUS SYSTEM. Endings of motor neurons are the terminals of axons at the muscle cells. Nerve endings which release neurotransmitters are called PRESYNAPTIC TERMINALS.
Glutamates
PC12 Cells
Vesicular Glutamate Transport Protein 1
Tyrosine 3-Monooxygenase
Vesicular Monoamine Transport Proteins
Action Potentials
Dose-Response Relationship, Drug
Biogenic Monoamines
Neural Inhibition
Vesicular Transport Proteins
A broad category of proteins involved in the formation, transport and dissolution of TRANSPORT VESICLES. They play a role in the intracellular transport of molecules contained within membrane vesicles. Vesicular transport proteins are distinguished from MEMBRANE TRANSPORT PROTEINS, which move molecules across membranes, by the mode in which the molecules are transported.
Vasoactive Intestinal Peptide
Glutamate Decarboxylase
A pyridoxal-phosphate protein that catalyzes the alpha-decarboxylation of L-glutamic acid to form gamma-aminobutyric acid and carbon dioxide. The enzyme is found in bacteria and in invertebrate and vertebrate nervous systems. It is the rate-limiting enzyme in determining GAMMA-AMINOBUTYRIC ACID levels in normal nervous tissues. The brain enzyme also acts on L-cysteate, L-cysteine sulfinate, and L-aspartate. EC 4.1.1.15.
Norepinephrine Plasma Membrane Transport Proteins
Sodium chloride-dependent neurotransmitter symporters located primarily on the PLASMA MEMBRANE of noradrenergic neurons. They remove NOREPINEPHRINE from the EXTRACELLULAR SPACE by high affinity reuptake into PRESYNAPTIC TERMINALS. It regulates signal amplitude and duration at noradrenergic synapses and is the target of ADRENERGIC UPTAKE INHIBITORS.
Molecular Sequence Data
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
Amino Acid Transport System X-AG
Rats, Wistar
Membrane Transport Proteins
Receptors, N-Methyl-D-Aspartate
A class of ionotropic glutamate receptors characterized by affinity for N-methyl-D-aspartate. NMDA receptors have an allosteric binding site for glycine which must be occupied for the channel to open efficiently and a site within the channel itself to which magnesium ions bind in a voltage-dependent manner. The positive voltage dependence of channel conductance and the high permeability of the conducting channel to calcium ions (as well as to monovalent cations) are important in excitotoxicity and neuronal plasticity.
Cerebral Cortex
Receptors, AMPA
Carrier Proteins
Tetrodotoxin
GABA Antagonists
Calcium Channels, P-Type
Models, Neurological
Microdialysis
Qa-SNARE Proteins
Receptors, Glycine
Neuropeptide Y
A 36-amino acid peptide present in many organs and in many sympathetic noradrenergic neurons. It has vasoconstrictor and natriuretic activity and regulates local blood flow, glandular secretion, and smooth muscle activity. The peptide also stimulates feeding and drinking behavior and influences secretion of pituitary hormones.
Loligo
Receptors, Serotonin
Membrane Proteins
Amino Acid Sequence
rab3 GTP-Binding Proteins
Central Nervous System
Vesicle-Associated Membrane Protein 2
Amino Acid Transport Systems, Neutral
Vesicular Acetylcholine Transport Proteins
6-Cyano-7-nitroquinoxaline-2,3-dione
Tetanus Toxin
Protein synthesized by CLOSTRIDIUM TETANI as a single chain of ~150 kDa with 35% sequence identity to BOTULINUM TOXIN that is cleaved to a light and a heavy chain that are linked by a single disulfide bond. Tetanolysin is the hemolytic and tetanospasmin is the neurotoxic principle. The toxin causes disruption of the inhibitory mechanisms of the CNS, thus permitting uncontrolled nervous activity, leading to fatal CONVULSIONS.
Serotonin Plasma Membrane Transport Proteins
Sodium chloride-dependent neurotransmitter symporters located primarily on the PLASMA MEMBRANE of serotonergic neurons. They are different than SEROTONIN RECEPTORS, which signal cellular responses to SEROTONIN. They remove SEROTONIN from the EXTRACELLULAR SPACE by high affinity reuptake into PRESYNAPTIC TERMINALS. Regulates signal amplitude and duration at serotonergic synapses and is the site of action of the SEROTONIN UPTAKE INHIBITORS.
Immunohistochemistry
5-Hydroxytryptophan
Receptors, Dopamine
Corpus Striatum
Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE.
Evoked Potentials
Electrical responses recorded from nerve, muscle, SENSORY RECEPTOR, or area of the CENTRAL NERVOUS SYSTEM following stimulation. They range from less than a microvolt to several microvolts. The evoked potential can be auditory (EVOKED POTENTIALS, AUDITORY), somatosensory (EVOKED POTENTIALS, SOMATOSENSORY), visual (EVOKED POTENTIALS, VISUAL), or motor (EVOKED POTENTIALS, MOTOR), or other modalities that have been reported.
Signal Transduction
The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway.
Mice, Knockout
Strains of mice in which certain GENES of their GENOMES have been disrupted, or "knocked-out". To produce knockouts, using RECOMBINANT DNA technology, the normal DNA sequence of the gene being studied is altered to prevent synthesis of a normal gene product. Cloned cells in which this DNA alteration is successful are then injected into mouse EMBRYOS to produce chimeric mice. The chimeric mice are then bred to yield a strain in which all the cells of the mouse contain the disrupted gene. Knockout mice are used as EXPERIMENTAL ANIMAL MODELS for diseases (DISEASE MODELS, ANIMAL) and to clarify the functions of the genes.
GABA Agonists
Receptors, Nicotinic
One of the two major classes of cholinergic receptors. Nicotinic receptors were originally distinguished by their preference for NICOTINE over MUSCARINE. They are generally divided into muscle-type and neuronal-type (previously ganglionic) based on pharmacology, and subunit composition of the receptors.
Neurotoxins
Neurochemistry
Dopamine Plasma Membrane Transport Proteins
Tryptophan Hydroxylase
Calcium Channel Blockers
Calcium Signaling
Signal transduction mechanisms whereby calcium mobilization (from outside the cell or from intracellular storage pools) to the cytoplasm is triggered by external stimuli. Calcium signals are often seen to propagate as waves, oscillations, spikes, sparks, or puffs. The calcium acts as an intracellular messenger by activating calcium-responsive proteins.
Vesicular Inhibitory Amino Acid Transport Proteins
omega-Conotoxin GVIA
Botulinum Toxins
Toxic proteins produced from the species CLOSTRIDIUM BOTULINUM. The toxins are synthesized as a single peptide chain which is processed into a mature protein consisting of a heavy chain and light chain joined via a disulfide bond. The botulinum toxin light chain is a zinc-dependent protease which is released from the heavy chain upon ENDOCYTOSIS into PRESYNAPTIC NERVE ENDINGS. Once inside the cell the botulinum toxin light chain cleaves specific SNARE proteins which are essential for secretion of ACETYLCHOLINE by SYNAPTIC VESICLES. This inhibition of acetylcholine release results in muscular PARALYSIS.
Receptors, Metabotropic Glutamate
Receptors, Presynaptic
Synaptophysin
Spinal Cord
Kainic Acid
(2S-(2 alpha,3 beta,4 beta))-2-Carboxy-4-(1-methylethenyl)-3-pyrrolidineacetic acid. Ascaricide obtained from the red alga Digenea simplex. It is a potent excitatory amino acid agonist at some types of excitatory amino acid receptors and has been used to discriminate among receptor types. Like many excitatory amino acid agonists it can cause neurotoxicity and has been used experimentally for that purpose.
Retina
The ten-layered nervous tissue membrane of the eye. It is continuous with the OPTIC NERVE and receives images of external objects and transmits visual impulses to the brain. Its outer surface is in contact with the CHOROID and the inner surface with the VITREOUS BODY. The outer-most layer is pigmented, whereas the inner nine layers are transparent.
N-Methylaspartate
omega-Conotoxins
Cerebellum
The part of brain that lies behind the BRAIN STEM in the posterior base of skull (CRANIAL FOSSA, POSTERIOR). It is also known as the "little brain" with convolutions similar to those of CEREBRAL CORTEX, inner white matter, and deep cerebellar nuclei. Its function is to coordinate voluntary movements, maintain balance, and learn motor skills.
Strychnine
Vesicular Glutamate Transport Protein 2
Sympathetic Nervous System
The thoracolumbar division of the autonomic nervous system. Sympathetic preganglionic fibers originate in neurons of the intermediolateral column of the spinal cord and project to the paravertebral and prevertebral ganglia, which in turn project to target organs. The sympathetic nervous system mediates the body's response to stressful situations, i.e., the fight or flight reactions. It often acts reciprocally to the parasympathetic system.
Aplysia
rab3A GTP-Binding Protein
Glutamine
Vesicular Biogenic Amine Transport Proteins
Baclofen
A GAMMA-AMINOBUTYRIC ACID derivative that is a specific agonist of GABA-B RECEPTORS. It is used in the treatment of MUSCLE SPASTICITY, especially that due to SPINAL CORD INJURIES. Its therapeutic effects result from actions at spinal and supraspinal sites, generally the reduction of excitatory transmission.
Mutation
Chromaffin Cells
Cells that store epinephrine secretory vesicles. During times of stress, the nervous system signals the vesicles to secrete their hormonal content. Their name derives from their ability to stain a brownish color with chromic salts. Characteristically, they are located in the adrenal medulla and paraganglia (PARAGANGLIA, CHROMAFFIN) of the sympathetic nervous system.
Receptors, Muscarinic
omega-Agatoxin IVA
Organic Anion Transporters
Substance P
Aspartic Acid
Drosophila
Ganglia, Sympathetic
Bicuculline
Biogenic Amines
A group of naturally occurring amines derived by enzymatic decarboxylation of the natural amino acids. Many have powerful physiological effects (e.g., histamine, serotonin, epinephrine, tyramine). Those derived from aromatic amino acids, and also their synthetic analogs (e.g., amphetamine), are of use in pharmacology.
Activity-dependent metaplasticity of inhibitory and excitatory synaptic transmission in the lamprey spinal cord locomotor network. (1/4009)
Paired intracellular recordings have been used to examine the activity-dependent plasticity and neuromodulator-induced metaplasticity of synaptic inputs from identified inhibitory and excitatory interneurons in the lamprey spinal cord. Trains of spikes at 5-20 Hz were used to mimic the frequency of spiking that occurs in network interneurons during NMDA or brainstem-evoked locomotor activity. Inputs from inhibitory and excitatory interneurons exhibited similar activity-dependent changes, with synaptic depression developing during the spike train. The level of depression reached was greater with lower stimulation frequencies. Significant activity-dependent depression of inputs from excitatory interneurons and inhibitory crossed caudal interneurons, which are central elements in the patterning of network activity, usually developed between the fifth and tenth spikes in the train. Because these interneurons typically fire bursts of up to five spikes during locomotor activity, this activity-dependent plasticity will presumably not contribute to the patterning of network activity. However, in the presence of the neuromodulators substance P and 5-HT, significant activity-dependent metaplasticity of these inputs developed over the first five spikes in the train. Substance P induced significant activity-dependent depression of inhibitory but potentiation of excitatory interneuron inputs, whereas 5-HT induced significant activity-dependent potentiation of both inhibitory and excitatory interneuron inputs. Because these metaplastic effects are consistent with the substance P and 5-HT-induced modulation of the network output, activity-dependent metaplasticity could be a potential mechanism underlying the coordination and modulation of rhythmic network activity. (+info)Reproducibility studies with 11C-DTBZ, a monoamine vesicular transporter inhibitor in healthy human subjects. (2/4009)
The reproducibility of (+/-)-alpha-[11C] dihydrotetrabenazine (DTBZ) measures in PET was studied in 10 healthy human subjects, aged 22-76 y. METHODS: The scan-to-scan variation of several measures used in PET data analysis was determined, including the radioactivity ratio (target-to-reference), plasma-input Logan total distribution volume (DV), plasma-input Logan Bmax/Kd and tissue-input Logan Bmax/Kd values. RESULTS: The radioactivity ratios, plasma-input Bmax/Kd and tissue-input Bmax/Kd all have higher reliability than plasma-input total DV values. In addition, measures using the occipital cortex as the reference region have higher reliability than the same measures using the cerebellum as the reference region. CONCLUSION: Our results show that DTBZ is a reliable PET tracer that provides reproducible in vivo measurement of striatal vesicular monoamine transporter density. In the selection of reference regions for DTBZ PET data analysis, caution must be exercised in circumstances when DTBZ binding in the occipital cortex or the cerebellum may be altered. (+info)Augmentation is a potentiation of the exocytotic process. (3/4009)
Short-term synaptic enhancement is caused by an increase in the probability with which synaptic terminals release transmitter in response to presynaptic action potentials. Since exocytosed vesicles are drawn from a readily releasable pool of packaged transmitter, enhancement must result either from an increase in the size of the pool or an elevation in the fraction of releasable vesicles that undergoes exocytosis with each action potential. We show here that at least one major component of enhancement, augmentation, is not caused by an increase in the size of the readily releasable pool but is instead associated with an increase in the efficiency with which action potentials induce the exocytosis of readily releasable vesicles. (+info)Role of mitochondrial dysfunction in the Ca2+-induced decline of transmitter release at K+-depolarized motor neuron terminals. (4/4009)
The present study tested whether a Ca2+-induced disruption of mitochondrial function was responsible for the decline in miniature endplate current (MEPC) frequency that occurs with nerve-muscle preparations maintained in a 35 mM potassium propionate (35 mM KP) solution containing elevated calcium. When the 35 mM KP contained control Ca2+ (1 mM), the MEPC frequency increased and remained elevated for many hours, and the mitochondria within twitch motor neuron terminals were similar in appearance to those in unstimulated terminals. All nerve terminals accumulated FM1-43 when the dye was present for the final 6 min of a 300-min exposure to 35 mM KP with control Ca2+. In contrast, when Ca2+ was increased to 3.6 mM in the 35 mM KP solution, the MEPC frequency initially reached frequencies >350 s-1 but then gradually fell approaching frequencies <50 s-1. A progressive swelling and eventual distortion of mitochondria within the twitch motor neuron terminals occurred during prolonged exposure to 35 mM KP with elevated Ca2+. After approximately 300 min in 35 mM KP with elevated Ca2+, only 58% of the twitch terminals accumulated FM1-43. The decline in MEPC frequency in 35 mM KP with elevated Ca2+ was less when 15 mM glucose was present or when preparations were pretreated with 10 microM oligomycin and then bathed in the 35 mM KP with glucose. When glucose was present, with or without oligomycin pretreatment, a greater percentage of twitch terminals accumulated FM1-43. However, the mitochondria in these preparations were still greatly swollen and distorted. We propose that prolonged depolarization of twitch motor neuron terminals by 35 mM KP with elevated Ca2+ produced a Ca2+-induced decrease in mitochondrial ATP production. Under these conditions, the cytosolic ATP/ADP ratio was decreased thereby compromising both transmitter release and refilling of recycled synaptic vesicles. The addition of glucose stimulated glycolysis which contributed to the maintenance of required ATP levels. (+info)Simultaneous measurement of evoked release and [Ca2+]i in a crayfish release bouton reveals high affinity of release to Ca2+. (5/4009)
The opener neuromuscular junction of crayfish was used to determine the affinity of the putative Ca2+ receptor(s) responsible for evoked release. Evoked, asynchronous release, and steady-state intracellular Ca2+ concentration, [Ca2+]ss, were measured concomitantly in single release boutons. It was found that, as expected, asynchronous release is highly correlated with [Ca2+]ss. Surprisingly, evoked release was also found to be highly correlated with [Ca2+]ss. The quantal content (m) and the rate of asynchronous release (S) showed sigmoidal dependence on [Ca2+]ss. The slope log m/log [Ca2+]ss varied between 1.6 and 3.3; the higher slope observed at the lower [Ca2+]o. The slope log S/log [Ca2+]ss varied between 3 and 4 and was independent of [Ca2+]o. These results are consistent with the assumption that evoked release is controlled by the sum of [Ca2+]ss and the local elevation of Ca2+ concentration near the release sites resulting from Ca2+ influx through voltage-gated Ca2+ channels (Y). On the basis of the above, we were able to estimate Y. We found Y to be significantly <10 microM even for [Ca2+]o = 13.5 mM. The dissociation constant (Kd) of the Ca2+ receptor(s) associated with evoked release was calculated to be in the range of 4-5 microM. This value of Kd is similar to that found previously for asynchronous release. (+info)D-Aspartate stimulation of testosterone synthesis in rat Leydig cells. (6/4009)
D-Aspartate increases human chorionic gonadotropin-induced testosterone production in purified rat Leydig cells. L-Aspartate, D-,L-glutamate or D-,L-asparagine could not substitute for D-aspartate and this effect was independent of glutamate receptor activation. Testosterone production was enhanced only in cells cultured with D-aspartate for more than 3 h. The increased production of testosterone was well correlated with the amounts of D-aspartate incorporated into the Leydig cells, and L-cysteine sulfinic acid, an inhibitor of D-aspartate uptake, suppressed both testosterone production and intracellular D-aspartate levels. D-Aspartate therefore is presumably taken up into cells to increase steroidogenesis. Intracellular D-aspartate probably acts on cholesterol translocation into the inner mitochondrial membrane, the rate-limiting process in steroidogenesis. (+info)Neuroregulation by vasoactive intestinal peptide (VIP) of mucus secretion in ferret trachea: activation of BK(Ca) channels and inhibition of neurotransmitter release. (7/4009)
1. The aims of this study were to determine: (1) whether vasoactive intestinal peptide (VIP) regulates cholinergic and 'sensory-efferent' (tachykininergic) 35SO4 labelled mucus output in ferret trachea in vitro, using a VIP antibody, (2) the class of potassium (K+) channel involved in VIP-regulation of cholinergic neural secretion using glibenclamide (an ATP-sensitive K+ (K(ATP)) channel inhibitor), iberiotoxin (a large conductance calcium activated K+ (BK(ca)) channel blocker), and apamin (a small conductance K(ca) (SK(ca)) channel blocker), and (3) the effect of VIP on cholinergic neurotransmission using [3H]-choline overflow as a marker for acetylcholine (ACh) release. 2. Exogenous VIP (1 and 10 microM) alone increased 35SO4 output by up to 53% above baseline, but suppressed (by up to 80% at 1 microM) cholinergic and tachykininergic neural secretion without altering secretion induced by ACh or substance P (1 microM each). Endogenous VIP accounted for the minor increase in non-adrenergic, non-cholinergic (NANC), non-tachykininergic neural secretion, which was compatible with the secretory response of exogenous VIP. 3. Iberiotoxin (3 microM), but not apamin (1 microM) or glibenclamide (0.1 microM), reversed the inhibition by VIP (10 nM) of cholinergic neural secretion. 4. Both endogenous VIP (by use of the VIP antibody; 1:500 dilution) and exogenous VIP (0.1 microM), the latter by 34%, inhibited ACh release from cholinergic nerve terminals and this suppression was completely reversed by iberiotoxin (0.1 microM). 5. We conclude that, in ferret trachea in vitro, endogenous VIP has dual activity whereby its small direct stimulatory action on mucus secretion is secondary to its marked regulation of cholinergic and tachykininergic neurogenic mucus secretion. Regulation is via inhibition of neurotransmitter release, consequent upon opening of BK(Ca) channels. In the context of neurogenic mucus secretion, we propose that VIP joins NO as a neurotransmitter of i-NANC nerves in ferret trachea. (+info)Profile of neurohumoral agents on mesenteric and intestinal blood flow in health and disease. (8/4009)
The mesenteric and intestinal blood flow is organized and regulated to support normal intestinal function, and the regulation of blood flow is, in part, determined by intestinal function itself. In the process of the development and adaptation of the intestinal mucosa for the support of the digestive processes and host defense mechanisms, and the muscle layers for propulsion of foodstuffs, a specialized microvascular architecture has evolved in each tissue layer. Compromised mesenteric and intestinal blood flow, which can be common in the elderly, may lead to devastating clinical consequences. This problem, which can be caused by vasospasm at the microvascular level, can cause intestinal ischaemia to any of the layers of the intestinal wall, and can initiate pathological events which promote significant clinical consequences such as diarrhea, abdominal angina and intestinal infarction. The objective of this review is to provide the reader with some general concepts of the mechanisms by which neurohumoral vasoactive substances influence mesenteric and intestinal arterial blood flow in health and disease with focus on transmural transport processes (absorption and secretion). The complex regulatory mechanisms of extrinsic (sympathetic-parasympathetic and endocrine) and intrinsic (enteric nervous system and humoral endocrine) components are presented. More extensive reviews of platelet function, atherosclerosis, hypertension, diabetes mellitus, the carcinoid syndrome, 5-hydroxytryptamine and nitric oxide regulation of vascular tone are presented in this context. The possible options of pharmacological intervention (e.g. vasodilator agonists and vasoconstrictor antagonists) used for the treatment of abnormal mesenteric and intestinal vascular states are also discussed. (+info)Putative Neurotransmitter Receptor - NLS320 | acris-antibodies.com
Homeostatic Control of Presynaptic Neurotransmitter Release - Zurich Open Repository and Archive
Komal Patel gutbrainconnection Although serotonin is well known as a brain neurotransmitter it is estimated that 90 percent of...
The impact of sildenafil citrate on neurotransmitter amino acids levels in brain tissue of albino rat. | Abstract
ModelDB: A dual-Ca2+-sensor model for neurotransmitter release in a central synapse (Sun et al. 2007)
Characterization of energy and neurotransmitter metabolism in cortical glutamatergic neurons derived from human induced...
Impact of Hypoglycemia on Brain Ketone and Neurotransmitter Metabolism in Type 1 DM > Clinical Research at Yale | Yale Center...
The mechanisms and functions of spontaneous neurotransmitter release
kenowapsychology - Neurotransmitters and their Effects
Most recent papers with the keyword hippocampus and epilepsy | Read by QxMD
Team:Princeton/Project Overview - 2008.igem.org
Neurotransmitter - PsychonautWiki
Neurology - emotion organs
Psychology
Psychosomatic Archives - Alternative Family Medicine
PND Association | Neurotransmitters Explained
NeuroPure - Pure Prescriptions
Are opioid peptides co-transmitters in noradrenergic vesicles of sympathetic nerves? - Semantic Scholar
Scalable sensor array platform for analysis of quantal transmitter release events - Manfred Lindau
regulation of neurotransmitter levels Antibodies | Invitrogen
...
Neurotransmitter - New World Encyclopedia
Marijuana Effects
Researchers uncover novel neurotransmitter system in the brain
IMP: Integrative Multi-species Prediction
2006-2007 Courses
Course Offerings
Peptide Neurotransmitters and Hormones
Neurotransmitters-A Primer
Mastering Nutrition: Living With MTHFR | 46
Diagnosed Bipolar, but Neurotransmitters normal? -Doctors Lounge(TM)
KEPOMPONG
GABA, 750mg, 180 ct - Ayurvedic Herbs Direct
MyEducationPath.com :: MIT OpenCourseWare (OCW) : Biochemistry and Pharmacology of Synaptic Transmission ...
GRK2 in Lymphocytes | Circulation Research
Glutamate and monoamine transporters: new visions of form and function
Chapter 4
9:02 pm
The Brain Whisperers
Forschungszentrum Jülich - Research
Heal Yourself At Home
Chapter 25 - Lock Down - Eyes Wide Shut: An Enigma | HubPages
Optimized Folate 1000 mcg 100 vcaps | Life Extension Foundation
Introducing Vitamin B6: Interacting in the Majority of Biological Reactions
Choose the Amino Acids | Julia Ross Cures
Higher Nature Brain Nutrients - 180 Vegicaps - Best before date is 28th February 2018 - UK Supplier
neurotransmitters - Neurotransmitters(ch 3 and Drugs(ch 6 Neurotransmitters Key terms Synaptic cleft Neurotransmitter Reuptake...
Neurotransmitter Test NeuroHormone Complete Panel Neurotransmitter,Hormone, Adrenal Test
Experiments
7.8 Molecular mechanism involved in neurotransmetter release IV - Neurotransmitter release | Coursera
stress
Serotonin-norepinephrine-dopamine reuptake inhibitor
"Effect of antidepressant agents on β-adrenergic receptor and neurotransmitter regulatory systems". Pharmacology Biochemistry ... Tetrabenazine, a similar agent to reserpine, which also depletes catecholamine stores, and to a lesser degree 5-HT, was shown ... The main neurotransmitter involved in the reward is dopamine, but other monoamines and acetylcholine may also participate. The ... In the case of SSRIs, the promiscuity among transporters means that there may be more than a single type of neurotransmitter to ...
HP-505
"Effect of antidepressant agents on beta-adrenergic receptor and neurotransmitter regulatory systems". Pharmacology, ... as potential central nervous system agents. 2. Compounds containing a heteroatom attached to nitrogen". Journal of Medicinal ...
GHB receptor
Castelli MP (October 2008). "Multi-faceted aspects of gamma-hydroxybutyric acid: a neurotransmitter, therapeutic agent and drug ... that binds the neurotransmitter and psychoactive drug γ-hydroxybutyric acid (GHB). As solute carrier family 52 member 2 ( ...
Chromesthesia
... can be transiently induced with chemical agents through the manipulation of neurotransmitters. These substances ... Luke DP, Terhune DB (October 2013). "The induction of synaesthesia with chemical agents: a systematic review". Frontiers in ... and hue are affected due to chemical agents. Drug-induced chromesthesia, as opposed to congenital chromesthesia, is not ... suggest that the induction of synesthesia with chemical agents is possible. Nevertheless, most studies "suffer from a large ...
Cyclopentamine
... acts as a releasing agent of the catecholamine neurotransmitters norepinephrine (noradrenaline), epinephrine ( ... while its effects on all three neurotransmitters are responsible for its stimulant properties. When ingested orally in ... Norepinephrine-dopamine releasing agents, Stimulants, Sympathomimetics, Cyclopentyl compounds). ...
Alcohol intoxication
In the past, alcohol was believed to be a non-specific pharmacological agent affecting many neurotransmitter systems in the ... Among the neurotransmitter systems with enhanced functions are: GABAA, 5-HT3 receptor agonism (responsible for GABAergic (GABAA ... The result of these direct effects is a wave of further indirect effects involving a variety of other neurotransmitter and ...
Serotonin-norepinephrine reuptake inhibitor
Selectivity of antidepressant agents are based on the neurotransmitters that are thought to influence symptoms of depression. ... Risk of overdose is increased in patients taking multiple serotonergic agents or interacting agents. Symptoms of SNRI overdose ... Repeated exposure of agents with this type of mechanism leads to inhibition of neurotransmitter release, but repeated ... These neurotransmitters are thought to play an important role in mood regulation. SNRIs can be contrasted with the more widely ...
Chronic diarrhea of infancy
Infectious agents include bacteria, viruses, and protozoans while non-infectious agents can be hormones, neurotransmitters, ... Secretory diarrhea can be caused by either infectious or non-infectious agents. ... infectious agents, and/or anatomical problems. Blood tests allow assessment of inflammatory markers and/or other criterion for ...
Tropomyosin
Smooth muscle may contract spontaneously or rhythmically and be induced by a number of physiochemical agents (hormones, drugs, ... neurotransmitters). Smooth muscle is found within the walls of various organs and tubes in the body such as the esophagus, ... This discovery has led to the development of novel anti-tropomyosin compounds as potential anti-cancer agents. Tropomyosins ...
6-APB
In addition, 6-APB not only blocks the reuptake of these monoamine neurotransmitters but is also a releasing agent of them; ... 6-APB and its structural isomer 5-APB have been tested with a series of agents including: Marquis, Liebermann, Mecke, and ... that is, it is a serotonin-norepinephrine-dopamine releasing agent (SNDRA). In addition to actions at the monoamine ... Serotonin-norepinephrine-dopamine releasing agents, Serotonin receptor agonists, Entactogens and empathogens). ...
Sarin
Like some other nerve agents that affect the neurotransmitter acetylcholine, sarin attacks the nervous system by interfering ... Along with nerve agents such as tabun and VX, sarin can have a short shelf life. Therefore, it is usually stored as two ... The nerve agents sarin and VX. Colourless and tasteless, they cause death by respiratory arrest in one to 15 minutes. Gussow, ... Chemical agent and munition disposal summary of the U.S. army's experience (PDF). United States Army. 1987. pp. B-30. Archived ...
3-Fluoroethamphetamine
... is a stimulant drug of the amphetamine class which acts as a releasing agent of the monoamine neurotransmitters norepinephrine ... Serotonin-norepinephrine-dopamine releasing agents, Stimulants, Substituted amphetamines). ...
Signal transduction
First messengers are the signaling molecules (hormones, neurotransmitters, and paracrine/autocrine agents) that reach the cell ... Moreover, some molecules may fit into more than one class, e.g. epinephrine is a neurotransmitter when secreted by the central ... For example, odorants belong to a wide range of molecular classes, as do neurotransmitters, which range in size from small ... In addition to nitric oxide, other electronically activated species are also signal-transducing agents in a process called ...
Nenitzescu indole synthesis
Among them are serotonin, a neurotransmitter; indometacin, a non-steroidal anti-inflammatory agent; L-761,066, a COX-2 ... including neurotransmitters and a new class of antitumor compounds. The mechanism of a Nenitzescu reaction consists of a ...
List of MeSH codes (D27)
... neurotransmitter agents MeSH D27.505.519.625.050 - adrenergic agents MeSH D27.505.519.625.050.100 - adrenergic agonists MeSH ... neurotransmitter agents MeSH D27.505.696.577.050 - adrenergic agents MeSH D27.505.696.577.050.100 - adrenergic agonists MeSH ... antiviral agents MeSH D27.505.954.122.388.077 - anti-retroviral agents MeSH D27.505.954.122.388.077.088 - anti-hiv agents MeSH ... tocolytic agents MeSH D27.505.954.016 - anti-allergic agents MeSH D27.505.954.122 - anti-infective agents MeSH D27.505.954.122. ...
Glutamic acid
Chelating agents, Glutamate (neurotransmitter), E-number additives). ... The glutamate neurotransmitter plays the principal role in neural activation. This anion creates the savory umami flavor of ... It is also the most abundant excitatory neurotransmitter in the vertebrate nervous system. It serves as the precursor for the ... Glutamate is also a neurotransmitter (see below), which makes it one of the most abundant molecules in the brain. Malignant ...
Reverse transport
... many monoamine releasing agents cause monoamine neurotransmitter efflux (i.e., the release of monoamine neurotransmitters from ... the reabsorption of neurotransmitters by the cell which released them). During neurotransmitter reuptake, neurotransmitter ... When these transporters operate in reverse, they produce neurotransmitter efflux (i.e., the movement of neurotransmitters from ... The primary function of most neurotransmitter transporters is to facilitate neurotransmitter reuptake (i.e., ...
Monoamine releasing agent
Selective for one neurotransmitter Serotonin releasing agent (SRA) Norepinephrine releasing agent (NRA) Dopamine releasing ... releasing two or more neurotransmitters Norepinephrine-dopamine releasing agent (NDRA) Serotonin-norepinephrine releasing agent ... Serotonin-norepinephrine-dopamine releasing agent (SNDRA) MRAs cause the release of monoamine neurotransmitters by various ... A monoamine releasing agent (MRA), or simply monoamine releaser, is a drug that induces the release of a monoamine ...
Obsessive-compulsive disorder
Much current research is devoted to the therapeutic potential of the agents that affect the release of the neurotransmitter ... Graat I, Figee M, Denys D. "Neurotransmitter Dysregulation in OCD". In Pittinger C (ed.). Obsessive-Compulsive Disorder: ... which is a neurotransmitter that some nerve cells use to communicate with each other, and is thought to be involved in ...
Iontophoresis
By microelectrophoretic techniques, including microiontophoresis, neurotransmitters and other chemical agents can be ... A small electric current is applied to an iontophoretic chamber placed on the skin, containing a charged active agent and its ... It drives a charged substance, usually a medication or bioactive agent, transdermally by repulsive electromotive force, through ...
Nerve agent
... a neurotransmitter. Nerve agents are acetylcholinesterase inhibitors used as poison. Poisoning by a nerve agent leads to ... All of the V-agents are persistent agents, meaning that these agents do not degrade or wash away easily and can therefore ... Nerve agents can also be absorbed through the skin, requiring that those likely to be subjected to such agents wear a full body ... Agents Sarin and VX are odorless; Tabun has a slightly fruity odor and Soman has a slight camphor odor. Nerve agents attack the ...
Monoamine-depleting agent
Monoamine-depleting agents are a group of drugs which reversibly deplete one or more monoamine neurotransmitters. One mechanism ... Examples of monoamine-depleting agents include deutetrabenazine, oxypertine, reserpine, tetrabenazine, and valbenazine. ... by which these agents act is by inhibiting reuptake by the vesicular monoamine transporters, VMAT1 and VMAT2. ...
Sibutramine
Older anorectic agents such as amphetamine and fenfluramine force the release of these neurotransmitters rather than affecting ... Fenfluramine, of the 1990s "Fen-Phen" combo, forced excess release of neurotransmitters-a different action. Phentermine was ...
Stephen J. Lippard
... and measuring metal ions as they interact with neurotransmitters and other biological signaling agents. Cisplatin is one of the ... Working at the interface of inorganic chemistry and neuroscience, he has devised fluorescent imaging agents for studying mobile ... Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs". Chemical Reviews. 116 (5): 3436-3486. doi:10.1021/acs.chemrev.5b00597. PMC ...
Norfenefrine
Norepinephrine-dopamine releasing agents, Neurotransmitters, Phenols, Phenylethanolamines, TAAR1 agonists, Trace amines, All ... Norfenefrine (INN; also known as meta-octopamine, 3-octopamine, and 3,β-dihydroxyphenethylamine) is an adrenergic agent used as ... Macdonald F (1997). Dictionary of Pharmacological Agents. CRC Press. p. 104. ISBN 978-0-412-46630-4. Retrieved 24 April 2012. ... endogenous trace amine and plays a role as a minor neurotransmitter in the brain. Some brand names for it include Coritat, ...
6-Hydroxymelatonin
Neuroprotective agents, Neurotransmitters, Phenols, Tryptamine alkaloids, Mexamines, All stub articles, Biochemistry stubs). ...
2-Methoxyamphetamine
... weaker in inhibiting the reuptake of and inducing the release of the monoamine neurotransmitters compared to related agents ...
Dopamine
Inotropic agents, Motivation, Neurotransmitters, Norepinephrine-dopamine releasing agents, TAAR1 agonists, Biology of attention ... Other neurotransmitters, such as serotonin and glutamate also show a decline in output with aging. Studies reported that ... Neurotransmitters are synthesized in specific regions of the brain, but affect many regions systemically. The brain includes ... Dopamine is used as a neurotransmitter in most multicellular animals. In sponges there is only a single report of the presence ...
Adrenaline
Neurotransmitters, Norepinephrine releasing agents, Stress (biology), Sympathomimetic amines, Chemical substances for emergency ... The term "adrenergic" is often misinterpreted in that the main sympathetic neurotransmitter is noradrenaline, rather than ... ISBN 978-0-9626523-7-0. von Bohlen und Haibach O, Dermietzel R (2006). Neurotransmitters and Neuromodulators: Handbook of ... mostly in scattered chromaffin cells and in a small number of neurons that use adrenaline as a neurotransmitter. Following ...
Smooth muscle
Also, contraction, as well as relaxation, can be induced by a number of physiochemical agents (e.g., hormones, drugs, ... neurotransmitters - particularly from the autonomic nervous system). Smooth muscle in various regions of the vascular tree, the ... A number of growth factors and neurohumoral agents influence smooth muscle growth and differentiation. The Notch receptor and ... various adrenergic receptors that explains the difference in why blood vessels from different areas respond to the same agent ...
R-type calcium channel
E-type Ca channels share dual roles during neurotransmitter release". The European Journal of Neuroscience. 21 (6): 1617-25. ... "Inhibition of human alpha1E subunit-mediated ca2+ channels by the antipsychotic agent chlorpromazine". Acta Physiologica ...
GABRA4
GABA is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated ... Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. At ...
Sympathoadrenal system
... ultimately releasing the neurotransmitter acetylcholine. The neurotransmitter acetylcholine causes the excitation of the nerves ... In these cases, curative agents such as adrenergic agonists and antagonists are used to modify epinephrine and norepinephrine ...
Doxepin
Sympathomimetic agents may have their effects potentiated by TCAs like doxepin. Doxepin also may potentiate the adverse effects ... Richelson E, Nelson A (July 1984). "Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro ... Antiarrhythmic agents may be an appropriate measure to treat cardiac arrhythmias resulting from doxepin overdose. Slow ... Antihypertensive agents may have their effects mitigated by doxepin. Cotreatment with CNS depressants such as the ...
Dementia with Lewy bodies
January 2022). "Infectious Agents as Potential Drivers of α-Synucleinopathies" (PDF). Mov Disord (Review). 37 (3): 464-477. doi ... Partly because of loss of cells that release the neurotransmitter dopamine, people with DLB may have neuroleptic malignant ... Neuronal loss in DLB leads to profound dopamine dysfunction and marked cholinergic pathology; other neurotransmitters might be ... Anticholinergic and dopaminergic agents can have adverse effects or result in psychosis in individuals with DLB, and a ...
CX717
It affects the neurotransmitter glutamate, with trials showing the drug improves cognitive functioning and memory. In 2005 the ... of the Type II Ampakine CX717 Is An Artifact Related to Molecular Structure and Chemical Reaction With Tissue Fixative Agents ...
Effects of cannabis
Marijuana smoke was listed as a cancer agent in California in 2009. A study by the British Lung Foundation published in 2012 ... This agonism of the cannabinoid receptors results in changes in the levels of various neurotransmitters, especially dopamine ... Mechoulam R (1984). Cannabinoids as therapeutic agents. Boca Raton, FL: CRC Press. ISBN 978-0-8493-5772-5.[page needed] Ad Hoc ... a pharmacologically active neurotransmitter) by upon metabolism of CBD. THC is converted rapidly to 11-hydroxy-THC, which is ...
Enzyme inhibitor
Zhang L, He J, Bai L, Ruan S, Yang T, Luo Y (July 2021). "Ribosome-targeting antibacterial agents: Advances, challenges, and ... It is essential to nerve cell function through its mechanism of breaking down the neurotransmitter acetylcholine into its ... Dalhoff A (February 2021). "Selective toxicity of antibacterial agents-still a valid concept or do we miss chances and ignore ... In addition, naturally produced poisons are often enzyme inhibitors that have evolved for use as toxic agents against predators ...
GABAA receptor positive allosteric modulator
GABA is a major inhibitory neurotransmitter in the central nervous system. Upon binding, it triggers the GABAA receptor to open ... Sedative actions of benzodiazepines limit their usefulness as analgesic agents and they are therefore generally not considered ... Neurosteroids can act as allosteric modulators of neurotransmitter receptors, such as the GABAA, NMDA, and sigma receptors. The ... neurotransmitter molecule: they affect the receptor by binding at a different site on the protein. This is called allosteric ...
Peter Medawar
... became a naturalised British citizen and worked for a British dental supplies manufacturer that sent him to Brazil as an agent ... "Evolution of neurotransmitter receptor systems". Progress in Neurobiology. 30 (2-3): 105-169. doi:10.1016/0301-0082(88)90004-4 ...
Binding selectivity
A ligand may be a peptide or another small molecule, such as a neurotransmitter, a hormone, a pharmaceutical drug, or a toxin. ... The further use of quantitative structure-activity relationships (QSAR) led to the development of other agents such as ... occurring siderophore produced by the actinobacter Streptomyces pilosus and was used initially as a chelation therapy agent. ...
Hippocampal memory encoding and retrieval
After receiving post-retrieval an intra-amygdalar infusion of a known amnesic agent, anisomycin, rats failed to recall a ... receptors by the surplus signaling of excitatory neurotransmitters. The depolarization and calcium overload experienced by ... phase is a short-lived destabilization of a memory object and a susceptibility for said object to react to amnesic agents- ...
Glaucoma
Tsai JC, Song BJ, Wu L, Forbes M (September 2007). "Erythropoietin: a candidate neuroprotective agent in the treatment of ... excitatory neurotransmitter, trophic factor, retinal ganglion cell/axon degeneration, glial support cell, immune system, aging ... involves the use of a novel group of medications known as anti-VEGF agents. These injectable medications can lead to a dramatic ... Miotic agents (parasympathomimetics), such as pilocarpine, work by contraction of the ciliary muscle, opening the trabecular ...
Hydroxyzine
Snowman AM, Snyder SH (December 1990). "Cetirizine: actions on neurotransmitter receptors". The Journal of Allergy and Clinical ... 532-. ISBN 978-3-88763-075-1. Morton IK, Hall JM (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties ... have been described as being an additional effect from overall central nervous system suppression by other CNS agents, such as ...
Competitive inhibition
Glycine is a major post-synaptic inhibitory neurotransmitter with a specific receptor site. Strychnine binds to an alternate ... Therefore, because of sulfa drugs' competitive inhibition, they are excellent antibacterial agents. An example of competitive ...
Rasagiline
At first, the N-methyl was necessary for the agent to be considered a ring cyclized analog of pargyline with ca. twenty-times ... An enzyme called monoamine oxidase (MAO) breaks down neurotransmitters. MAO has two forms, MAO-A and MAO-B. MAO-B is generally ... While these metabolites may contribute to selegiline's ability to inhibit reuptake of the neurotransmitters dopamine and ... Parkinson's disease is characterized by the death of cells that produce dopamine, a neurotransmitter. ...
Neuroimmunology
... and neurotransmitter systems. For example, brain cytokine levels increase following stress exposure, while treatments designed ... use of epigenetic therapeutic agents may help reverse complex pathogenic processes. Multiple sclerosis (MS) is one type of ... Neural fate decisions include the utilization of multiple neurotransmitter signal pathways along with the use of epigenetic ... that have a broad set of biochemical modifications and can affect DNA demethylation and synergy with other therapeutic agents. ...
Catechol
Chelating agents, Enediols, IARC Group 2B carcinogens, Photographic chemicals, Reducing agents). ... hormones/neurotransmitters Dopamine, derived from the amino acid tyrosine, an adhesive used by mussels. Quercetin, which is ... urushiols, the active agent in poison ivy (R = (CH2)14CH3, (CH2)7CH=CHCH2CH=CHCH2CH=CH2, and others) catecholamines, drugs ...
Exhaled nitric oxide
Today, NO is not only used in breath tests but also as a therapeutic agent for conditions such as pulmonary arterial ... After scientists realised that NO played a biological role, its role as a cell signalling molecule and neurotransmitter became ... agents that relax the blood vessels). eNO has also been associated with wheeze, rhinitis and nasal allergy in primary school ...
Drugs and sexual desire
Neurotransmitters play essential roles in stimulating and inhibiting the processes that lead to libido production in both men ... Vallejos, Ximena; Wu, Christine (2017-04-01). "Flibanserin: A Novel, Nonhormonal Agent for the Treatment of Hypoactive Sexual ... Due to the fact that serotonin can interfere with other neurotransmitters and hormones, for instance, sex hormones, SSRIs can ... Drugs acting on the above neurotransmitters can be used to upregulate or downregulate sexual desire due to diseased conditions ...
Generalized anxiety disorder
... and also implicated in neurotransmitters and neurotransmitter receptors known to be involved in anxiety disorders. More ... Like other serotonergic agents, SNRIs have the potential to cause serotonin syndrome, a potentially fatal systemic response to ... Overdose of an SSRI or concomitant use with another agent that causes increased levels of serotonin can result in serotonin ... It acts on the voltage-dependent calcium channel to decrease the release of neurotransmitters such as glutamate, norepinephrine ...
Diazinon
This enzyme breaks down the neurotransmitter acetylcholine (ACh) into choline and an acetate group. The inhibition of AChE ... "Atropine availability as an antidote for nerve agent casualties: Validated rapid reformulation of high-concentration atropine ... As mentioned above, diazinon inhibits the enzyme acetylcholinesterase (AChE), which hydrolyzes the neurotransmitter ...
Phenethylamine
To a lesser extent, it also acts as a neurotransmitter in the human central nervous system. In mammals, phenethylamine is ... antiparkinson agents (e.g., selegiline), and vasopressors (e.g., ephedrine), among others. Many of these psychoactive compounds ... Godfrey, Peter D.; Hatherley, Lynette D.; Brown, Ronald D. (1 August 1995). "The Shapes of Neurotransmitters by Millimeter-Wave ... Brain levels of endogenous trace amines are several hundred-fold below those for the classical neurotransmitters noradrenaline ...
Biogenic substance
Biogenic neurotransmitters. An abiogenic substance or process does not result from the present or past activity of living ... Environmentally safe alternatives are needed to TBT (tin-based antifouling agent) which releases toxic compounds into water and ... making them a potential nanomaterials agent. Another procedure is through the use of a different biogenic substance: the ...
Lipid signaling
Chemotherapeutic agents such as daunorubicin and etoposide enhance the de novo synthesis of ceramide in studies done on ... In this regard intact PIP2 signals as a bona fide neurotransmitter-like ligand. PIP2's interaction with many ion channels ... studies in cells have shown that ceramide-inducing agents such as tumor necrosis factor-alpha α (TNFα) and palmitate induce the ... GluCer is implicated in post-Golgi trafficking and drug resistance particularly to chemotherapeutic agents. For instance, a ...
Spinal cord injury
These secondary injury pathways include the ischemic cascade, inflammation, swelling, cell suicide, and neurotransmitter ... Several potentially neuroprotective agents that target pathways like these are under investigation in human clinical trials. ...
Benzodiazepine overdose
Nelson LH, Flomenbaum N, Goldfrank LR, Hoffman RL, Howland MD, Neal AL (2006). "Sedative-hypnotic agents". Goldfrank's ... Benzodiazepines bind to a specific benzodiazepine receptor, thereby enhancing the effect of the neurotransmitter gamma- ...
ELOM-080
Poole P, Sathananthan K, Fortescue R (May 2019). "Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive ... rhinosinusitis or in bronchial asthma are caused by various inflammatory cells and neurotransmitters (inflammation mediators). ...
Yohimbine
Blockade of pre-synaptic α2 receptors facilitates the release of several neurotransmitters in the central and peripheral ... Norepinephrine releasing agents, Stimulants, Sympathomimetics, Vasoconstrictors, Vasodilators). ...
Ligand binding assay
These estimates are measured by examining how a ligand binds to a receptor while simultaneously reacting to a substitute agent ... Hormones and neurotransmitters are essential endogenous regulatory ligands that affect physiological receptors within an ... Specifically, despite the human body's endogenous receptors, hormones, and other neurotransmitters, pharmacologists utilize ...
Dynamic modulation of inflammatory pain-related affective and sensory symptoms by optical control of amygdala metabotropic...
Effects of Neupro on Cardiovascular Observations in Patients With Restless Legs Syndrome - Full Text View - ClinicalTrials.gov
RCSB PDB - S7Y Ligand Summary Page
Current version of study NCT03527316 on ClinicalTrials.gov
DeCS 2006 - Deleted terms
Amino Acid Neurotransmitters. Neurotransmitter Agents. Anti-Inflammatory Agents, Antirheumatic Agents, and Inflammation ... Neurotransmitters. Neurotransmitter Agents. Neurotransmitters and Neurotransmitter Agents. Neurotransmitter Agents. Virus ... Anti-Bacterial Agents. Antineoplastic and Immunosuppressive Agents. Antineoplastic Agents. Antirheumatic Agents, Gold. ...
The relationship between dopamine neurotransmitter dynamics and the blood-oxygen-level-dependent (BOLD) signal: A review of...
Characterizing the effects of neuropharmacological agents on regional brain activity using fMRI is challenging because drugs ... and neurotransmitter reuptake blocker events. Here we review current knowledge on neurotransmitter-mediated blood-oxygen-level ... and neurotransmitter reuptake blocker events. Here we review current knowledge on neurotransmitter-mediated blood-oxygen-level ... and neurotransmitter reuptake blocker events. Here we review current knowledge on neurotransmitter-mediated blood-oxygen-level ...
Trochlear Nerve Palsy (Fourth Nerve Palsy) Treatment & Management: Medical Therapy, Surgical Therapy, Preoperative Details
EP2155696A2 - Piperazine salts as d3/d2 antagonists - Google Patents
239000002858 neurotransmitter agent Substances 0.000 description 1 * 229930015196 nicotine Natural products 0.000 description 1 ... When the active agent has insufficient solubility in water, the agent typically must be converted into a form which has the ... The formulation may also contain one or more suspending agents, preservative, flavouring or colouring agent. ... 239000003176 neuroleptic agent Substances 0.000 claims description 6 * 238000000634 powder X-ray diffraction Methods 0.000 ...
Psychopharmacology | Psychology Today Ireland
It also includes agents that relieve acute and chronic pain, and others that curb insomnia and facilitate sleep. ... Such agents induce changes in mood, sensation, thinking, or behavior, and may be derived from plants or other natural sources ... Such agents typically act on one or another neurotransmitter, but since each neurotransmitter system influences many functions ... Antipsychotic agents generally target dopamine receptors to reduce activity of the neurotransmitter. Because dopamine levels ...
Software for near-real-time voltammetric tracking of tonic neurotransmitter levels in vivo<...
Neurotransmitter Agents Medicine & Life Sciences 100% * Software Medicine & Life Sciences 86% * Psychological Handling Medicine ... Software for near-real-time voltammetric tracking of tonic neurotransmitter levels in vivo. Frontiers in Neuroscience. 2022 Sep ... Software for near-real-time voltammetric tracking of tonic neurotransmitter levels in vivo. In: Frontiers in Neuroscience. 2022 ... Dive into the research topics of Software for near-real-time voltammetric tracking of tonic neurotransmitter levels in vivo. ...
Cholinergic Agonists | Harvard Catalyst Profiles | Harvard Catalyst
Chromesthesia - Wikipedia
Chromesthesia can be transiently induced with chemical agents through the manipulation of neurotransmitters. These substances ... and hue are affected due to chemical agents. Drug-induced chromesthesia, as opposed to congenital chromesthesia, is not ... suggest that the induction of synesthesia with chemical agents is possible. Nevertheless, most studies "suffer from a large ... One theory that explains how this occurs is neurotransmitter-mediated inhibition. Local inhibitory networks are supposed to ...
ChemIDplus - 96-64-0 - GRXKLBBBQUKJJZ-UHFFFAOYSA-N - Soman - Similar structures search, synonyms, formulas, resource links, and...
Adenosine A2 Receptor Agonists | Profiles RNS
Dopamine and Psychosis
A neurotransmitter is a chemical agent that nerve cells use to transmit information to other nerve cells or muscle or gland ... They believe that the neurotransmitter dopamine plays a key role.. Neuroscience eBook. Compilation of the top interviews, ... Other neurotransmitters. Recent research has suggested that dopamine perturbations alone may not fully account for the clinical ...
Tourette's syndrome: From behaviour to biology<...
Antipsychotic Agents Medicine & Life Sciences 23% * Neuroimaging Medicine & Life Sciences 23% * Neurotransmitter Agents ... but the definitive pathophysiological mechanism or neurotransmitter abnormality is unknown. Recent evidence, however, suggests ... but the definitive pathophysiological mechanism or neurotransmitter abnormality is unknown. Recent evidence, however, suggests ... but the definitive pathophysiological mechanism or neurotransmitter abnormality is unknown. Recent evidence, however, suggests ...
Iris Publication
Animals, Electric Conductivity, Glutamates, Ion Channels, Kinetics, Mathematics, Models, Biological, Neurotransmitter Agents, ... For ion channels that are opened by neurotransmitters, analysis of current noise has given valuable information on the kinetics ... we have recently characterized a synaptic current for which the neurotransmitter glutamate closes channels, and for which the ...
AUTOIMMUNE DISEASES CAUSED BY AN INFECTION? | Page 27 | Cassiopaea Forum
In summary infectious agents might influence the cerebral neurotransmitter balance via activating on the tryptophan catabolism ... if an infectious agent is what causes the cascade of events that lead to the immune system disturbance and/or neurotransmitter ... Moreover, antibodies against tryptophan, the decreased concentration of the neurotransmitter serotonin in the brain following ... Most of the above supposes that the infectious agent literally hijacks the host cells and takes full control including ...
Altered motor, anxiety-related and attentional task performance at baseline associate with multiple gene copies of the...
LRRK2 Affects Vesicle Trafficking, Neurotransmitter Extracellular Level and Membrane Receptor Localization<...
Neurotransmitter Agents Medicine & Life Sciences 78% * phosphotransferases (kinases) Agriculture & Biology 76% * ... LRRK2 Affects Vesicle Trafficking, Neurotransmitter Extracellular Level and Membrane Receptor Localization. PLoS One. 2013 Oct ... LRRK2 Affects Vesicle Trafficking, Neurotransmitter Extracellular Level and Membrane Receptor Localization. In: PLoS One. 2013 ... LRRK2 Affects Vesicle Trafficking, Neurotransmitter Extracellular Level and Membrane Receptor Localization. Rossana Migheli, ...
Tardive Dyskinesia: Overview, Pathophysiology, Etiology
Although they are associated with the use of neuroleptics, TDs apparently existed before the development of these agents. ... When TD is diagnosed, reduce or discontinue the causative agent if possible. [33, 34, 42, 43, 41, 49, 35, 36, 37, 38] The risk ... These findings provide evidence that adenosine, a major inhibitory neurotransmitter in the CNS, plays a role in TD. ... Other therapeutic agents for which there is some anecdotal support include vitamin E, levodopa (see carbidopa/levodopa), ...
Effects of general anaesthesia with an inhalational anaesthetic agent on the expression of exosomes in rats
They have investigated the effects of an inhalational anaesthetic agent on neurotransmitter-related ion channels on individual ... The mechanism of inhalational anaesthetic agents remains controversial. It is known to be associated with neurotransmitters and ... The inhalational anaesthetic agent is distributed in the blood to the brain. The inhalational anaesthetic agent is thought to ... The exact mechanism of inhalational anaesthetic agents is not completely known. The inspired inhalational anaesthetic agent is ...
Frontiers | Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options
The pathways and neurotransmitters reviewed include serotonergic agents, glutamate modulators, GABAergic medications, ... The pathways and neurotransmitters reviewed include serotonergic agents, glutamate modulators, GABAergic medications, ... Although there are some recent randomized controlled trials for novel agents including neuropeptides, glutamatergic agents ( ... neuropeptides, neurosteroids, alpha- and beta-adrenergic agents, cannabinoids, and natural remedies. The outcome of the review ...
Devil's Snare Growing on Nantucket Island
Hyoscyamine is an anticholinergic agent which means it blocks the neurotransmitter acetylcholine in the central and the ... The active anti-asthmatic agent is atropine, which causes paralysis of the pulmonary branches of the lungs, eliminating the ... Anticholinergics inhibit parasympathetic nerve impulses by selectively blocking the binding of the neurotransmitter ...
Two UCSD Research Projects Awarded NIH Counter-terrorist Grants
But when a nerve agent interacts with this protein, the normal transmissions of these neurotransmitters are disrupted. ... Both agents have significant side effects and serious limitations in treating large number of victims as they must be either ... Degrading the toxicity of nerve gas agents Nerve gas is another chemical weapon that was used by Sadam Hussien on Kurdish ... Chemical threats are defined by the NIH as toxic chemical agents that could be used in a terrorist attack against civilians, or ...
Modulation of extracellular neurotransmitter levels in the nucleus accumbens by a taurine uptake inhibitor<...
Neurotransmitter Agents Medicine & Life Sciences 45% * Microdialysis Medicine & Life Sciences 11% * Aspartic Acid Medicine & ... Modulation of extracellular neurotransmitter levels in the nucleus accumbens by a taurine uptake inhibitor. / Olive, M. Foster ... Modulation of extracellular neurotransmitter levels in the nucleus accumbens by a taurine uptake inhibitor. European Journal of ... Olive, M. F., Mehmert, K. K., & Hodge, C. W. (2000). Modulation of extracellular neurotransmitter levels in the nucleus ...
SerotoninAcetylcholineDopamineGlutamateGABASynapsesNeuronsExtracellular neurotransmitterReceptorsSubstancesCytokinesSynaptic TransmissionNerveAmino acidsMetabolismSchizophreniaModulationAnxietyDegradationLipidBrainDrugsConcentrationsMiceBehaviorInflammationVivoBindsSarinDisturbancesBiologicalOrgansMedicineDecreaseInduceAcuteMechanismEvidencePeripheralBacteriaChemicalEffectsReleasePotentiallyTherapeuticTissueDepressionCausativeInfectious agentsMoodInflammatory
Serotonin5
- Furthermore, dance/movement therapy boosts the synthesis of serotonin, a mood-regulating neurotransmitter generated by cells. (actressnews.info)
- Serotonin is a neurotransmitter that regulates social behavior and mood. (naturalwellnessorganics.com)
- Most notably, inhalation of essential oils can communicate signals to the olfactory system and stimulate the brain to exert neurotransmitters (e.g. serotonin and dopamine), thereby further regulating mood. (oil-testimonials.com)
- The inflammatory response system works by activating the hypothalamic-pituitary-adrenal axis, which affects the regulation of certain neurotransmitters such as serotonin and catecholamines, directly linked to depressive states. (psychologysays.net)
- One such study found that oral consumption of G. Lucidum triterpene acids promoted sleep in mice by increasing levels of a sleep-promoting neurotransmitter (serotonin) and optimising gut bacteria composition 8 . (elitenaturalhealthcare.com)
Acetylcholine8
- AChE accelerates or catalyzes the breakdown of the neurotransmitter acetylcholine, allowing normal neural transmissions across synapses in nerve and muscle tissue to occur. (ucsd.edu)
- Acetylcholine is a neurotransmitter (a chemical messenger) released by the nerves for the contraction of muscles. (rxlist.com)
- They block the action of a neurotransmitter called "acetylcholine" in the central and peripheral nervous systems. (rxlist.com)
- Botox is a nerve blocking agent that prevents the release of acetylcholine, a neurotransmitter that causes your muscles to contract. (flintrehab.com)
- It works by blocking the effects of a neurotransmitter called acetylcholine, which is responsible for causing contraction of muscles, increase in body secretions, and decrease in heart rate. (netmeds.com)
- It effectively restores cardiac activity and body function by blocking the effects of a neurotransmitter called acetylcholine in the body which is responsible for various physiological functions (such as contraction of skeletal or smooth muscles, increase in body secretions or bowel movements, and decrease in heart rate). (netmeds.com)
- It releases acetylcholine, a neurotransmitter that helps to preserve mental balance and enhance the memory muscles. (thebestfashion.co)
- One of the neurologic processes affected by inflammation is with the neurotransmitters Acetylcholine and butyrycholine. (dragoosoilblends.com)
Dopamine4
- They believe that the neurotransmitter dopamine plays a key role. (news-medical.net)
- Dopamine is a catecholamine neurotransmitter used to treat Cardiogenic shock, Chronic refractory congestive cardiac failure, low doses in renal failure, dilated Cardiomyopathy, hemodynamic imbalances, poor perfusion of vital organs, low cardiac. (medicoinfo.org)
- Because high dopamine levels can be an explanation for the depressive phase of patients in the predominant psychomotor depletion, this finding was a possible indication that dopaminergic agents such as bupropion, MAO-Hemmer, or amphetamines could be helpful to our patient. (genomind.com)
- In particular, there is some evidence of a stimulating role of citicoline for the release of dopamine neurotransmitters in the brain. (thehouseofgoodies.com)
Glutamate3
- In depolarizing bipolar cells of the vertebrate retina, we have recently characterized a synaptic current for which the neurotransmitter glutamate closes channels, and for which the channel open probability is low even in the absence of glutamate. (ucl.ac.uk)
- With epileptic seizures being mediated by the neurotransmitter glutamate, the agent is a highly selective, noncompetitive AMPA receptor antagonist that reduces neuronal hyperexcitation associated with seizures by targeting glutamate activity at AMPA receptors on postsynaptic membranes. (eisai.com)
- Several of the recently identified genetic risk factors for schizophrenia also influence neurotransmitter and synaptic function, with some convergence on glutamate. (researchgate.net)
GABA5
- Most drugs that relieve anxiety in one way or another exert an effect on the neurotransmitter gamma-aminobutyric acid (GABA). (psychologytoday.com)
- A compound that inhibits the re-uptake of the neurotransmitter GABA from the synapse into the pre-synaptic neuron, so increasing the extracellular concentrations of the neurotransmitter and hence increasing neurotransmission. (zfin.org)
- The original work found that an anti-malaria drug or the neurotransmitter GABA could increase the number of insulin-producing pancreatic cells in mice. (the-scientist.com)
- In one, the scientists injected animals with the neurotransmitter GABA, which they reported could convert cells in the pancreas to insulin-producing β cells, and in the other they identified an anti-malaria compound that could convert pancreatic α cells to β-like cells and induce insulin production. (the-scientist.com)
- Some experts believe that they work by reducing the level of the neurotransmitter GABA (gamma-aminobutyric acid), which is primarily responsible for regulating mood. (hemp.shopping)
Synapses1
- Why synapses release a certain amount of neurotransmitter is poorly understood. (elsevier.com)
Neurons1
- It is considered an inhibitory neurotransmitter, which means it regulates brain and nerve cell activity by inhibiting the number of neurons firing in the brain. (mariamindbodyhealth.com)
Extracellular neurotransmitter3
- Tonic extracellular neurotransmitter concentrations are important modulators of central network homeostasis. (elsevier.com)
- Olive, MF , Mehmert, KK & Hodge, CW 2000, ' Modulation of extracellular neurotransmitter levels in the nucleus accumbens by a taurine uptake inhibitor ', European Journal of Pharmacology , vol. 409, no. 3, pp. 291-294. (elsevier.com)
- Hodge, Clyde W. / Modulation of extracellular neurotransmitter levels in the nucleus accumbens by a taurine uptake inhibitor . (elsevier.com)
Receptors1
- It produces neurotransmitters (endocannabinoids) which binds to the cannabinoid receptors in the nervous system. (naturalwellnessorganics.com)
Substances4
- People with schizophrenia and other neuropsychiatric disorders are especially vulnerable to the development of TDs after exposure to conventional neuroleptics, anticholinergics, toxins, substances of abuse, and other agents. (medscape.com)
- Substances used for their pharmacological actions on any aspect of neurotransmitter systems. (nih.gov)
- When the worms were incubated in DEC, substances known to have neurotransmitter effect were found increased except glycine. (who.int)
- Some studies have shown that laboratory inoculation of inflammatory substances or agents, it causes a number of symptoms typical of clinical pictures of depression and anxiety . (psychologysays.net)
Cytokines2
- A probable mechanism of how infections can influence the cerebral immune balance could be the activation of the tryptophan catabolism via infectious agents and elevated proinflammatory cytokines. (cassiopaea.org)
- This theory starts from the idea that when our body falls victim to some kind of infection, our own body emits an inflammatory response whereby a series of hemodynamic alterations, lymphatic levels and the release of a series of agents such as cytokines, histamine neuropeptides, etc., are carried out in order to restore the health of our body. (psychologysays.net)
Synaptic Transmission1
- CNS damage typically results from disruption of neurotransmitter metabolism and inhibition of synaptic transmission. (cdc.gov)
Nerve6
- Use of this agent as primary therapy for fourth nerve palsy has been discouraging. (medscape.com)
- A neurotransmitter is a chemical agent that nerve cells use to transmit information to other nerve cells or muscle or gland cells. (news-medical.net)
- Taylor's project focuses on creating a modified, synthetic version of AChE, an enzyme in nerve tissue that is the target protein of nerve gas agents. (ucsd.edu)
- But when a nerve agent interacts with this protein, the normal transmissions of these neurotransmitters are disrupted. (ucsd.edu)
- Soldier wounded from nerve agents. (wearethemighty.com)
- Nerve agents like VX and Sarin gases break down the neurotransmitters that make organs function. (wearethemighty.com)
Amino acids2
- IMSEAR at SEARO: Effect of diethyl carbamazine on neurotransmitter amino acids, biogenic amines and certain related enzymes in Setaria digitata. (who.int)
- Effect of diethyl carbamazine (DEC) on the levels of neurotransmitter amino acids and on the activities of related enzymes of S. digitata have been studied. (who.int)
Metabolism1
- Our findings thus suggest that exposure to GWI-related agents may converge on similar targets with roles in inflammation, neurotransmitter and lipid metabolism, and detoxification which may have impacts on neurodegenerative-like disease and oxidative stress in Veterans with GWI. (cdc.gov)
Schizophrenia2
- Despite numerous studies performed to reveal relation between infectious agents and schizophrenia, it is still controversial whether infectious agents play a causal role in inducing psychotic symptoms. (cassiopaea.org)
- Recent epidemiologic studies indicate that infectious agents may contribute to some cases of schizophrenia. (cdc.gov)
Modulation1
- The development of these agents was achieved by systematic molecular design that integrated several structural elements, including the aminoethyl group (VMAT recognition), halogenated hydroxy-coumarin core (ratiometric optical pH sensing in the desired pH range), and N- or C-alkylation (modulation of lipophilicity). (columbia.edu)
Anxiety9
- Second, we will review novel pharmacotherapeutic agents under investigation for the treatment of anxiety disorders in adults. (frontiersin.org)
- The outcome of the review reveals a lack of randomized double-blind placebo- controlled trials for anxiety disorders and few studies comparing novel treatments to existing anxiolytic agents. (frontiersin.org)
- Overall, the progression of current and future psychopharmacology research in anxiety disorders suggests that there needs to be further expansion in research of these novel pathways and larger-scale studies of promising agents with positive results from smaller trials. (frontiersin.org)
- Coping with anxiety does not necessitate the use of alcohol as a numbing agent. (actressnews.info)
- Alcohol can disrupt the neurotransmitters that regulate anxiety, making it difficult to have a decent night's sleep. (actressnews.info)
- Associated topics: mood-swings,stress-/-tension-/-burnout,anxiety-/-worry - "A number of essential oils are currently in use as aromatherapy agents to relieve anxiety, stress, and depression. (oil-testimonials.com)
- These neurotransmitters also improve focus, stamina, learning, and more and help in avoiding brain disorders like depression, anxiety, stress, and other conditions related to memory and learning. (australiansupp.com)
- Often, they're made with herbs that affect specific neurotransmitters to potentially improve sleep quality, decrease stress and anxiety, and help you fall asleep faster. (teacurry.com)
- There's no medical study that proves CBD works, but CBD has a reputation as a powerful anti-anxiety and anti-psychotic agent. (hemp.shopping)
Degradation1
- Monoamine oxidase is an enzyme that catalyzes the degradation of various neurotransmitters, reducing their effects in the brain and peripheral organs. (integrativepharmacology.com)
Lipid1
- A metanalysis performed on the entire database available from the clinical studies performed with this compound confirms the experimental evidence from the animal studies which have repeatedly described the multiple biological actions of citicoline in restoring both the cell lipid structures and some neurotransmitter functions. (thehouseofgoodies.com)
Brain10
- Characterizing the effects of neuropharmacological agents on regional brain activity using fMRI is challenging because drugs modulate neuronal function in a wide variety of ways, including through receptor agonist, antagonist, and neurotransmitter reuptake blocker events. (umn.edu)
- Brain imaging, neurophysiological, and post-mortem studies support involvement of cortical-striatal-thalamocortical pathways, but the definitive pathophysiological mechanism or neurotransmitter abnormality is unknown. (elsevier.com)
- The inhalational anaesthetic agent is distributed in the blood to the brain. (medsci.org)
- The inhalational anaesthetic agent is thought to affect communication between the alveoli, the blood, and the brain [ 1 ]. (medsci.org)
- For example, people with fetal alcohol syndrome, other developmental disabilities, and other brain disorders are vulnerable to the development of TDs, even after receiving only 1 dose of the causative agent. (medscape.com)
- Simultaneous acquisition SPECT brain imaging using a 99m Tc labeled perfusion agent and an 123 I labeled neurotransmitter agent has potential applications in diagnosis of neurodegenerative diseases. (elsevier.com)
- abstract = "Simultaneous acquisition SPECT brain imaging using a 99mTc labeled perfusion agent and an 123I labeled neurotransmitter agent has potential applications in diagnosis of neurodegenerative diseases. (elsevier.com)
- People with depression and other mental health conditions may benefit from the vitamins and antioxidants in moringa, which work together to stabilize neurotransmitters in the brain and may work in a similar way to SSRIs. (atavah.com)
- These neurotransmitters carry signals from cell to cell in the brain - they allow thinking, talking, remembering, and functioning to take place. (dragoosoilblends.com)
- It enhances the content of various neurotransmitters in the body that keep the brain healthy and stress-free. (australiansupp.com)
Drugs2
- While some psychoactive agents play an important role in reducing the suffering of those with illness, others, such as "smart drugs," are of increasing interest for enhancing mental capabilities in healthy people. (psychologytoday.com)
- Compare and contrast other analgesic agents that can be used in a multimodal approach to pain management, including nonsteroidal anti-inflammatory drugs (NSAIDs), antidepressants, and local anesthetics. (netce.com)
Concentrations2
- Previously published voltammetric software packages have implemented FSCV, which is not capable of measuring tonic concentrations of neurotransmitters in vivo. (elsevier.com)
- In this paper, custom software was developed for near-real-time tracking (scans every 10 s) of neurotransmitters' tonic concentrations with high sensitivity and spatiotemporal resolution both in vitro and in vivo using cyclic voltammetry combined with dynamic background subtraction (M-CSWV and FSCAV). (elsevier.com)
Mice1
- That study (cited 66 times) demonstrated that by regularly injecting mice with the neurotransmitter a large proportion of α cells would convert to β cells in wildtype animals or those chemically induced to have diabetes. (the-scientist.com)
Behavior2
- Such agents induce changes in mood, sensation, thinking, or behavior, and may be derived from plants or other natural sources or chemically synthesized in a laboratory. (psychologytoday.com)
- In animals, infection with Toxoplasma gondii can alter behavior and neurotransmitter function. (cdc.gov)
Inflammation1
- CBD helps to relieve chronic pain by influencing the endocannabinoid receptor activity, anti-inflammation and interacting with the neurotransmitters. (naturalwellnessorganics.com)
Vivo1
- Using in vivo microdialysis, we examined the effect of local perfusion of the taurine uptake inhibitor guanidinoethyl sulfonate on extracellular levels of various neurotransmitters in the rat nucleus accumbens. (elsevier.com)
Binds1
- NOREPINEPHRINE is one of the body's primary fat burning agents ), but when estrogen binds to the A2A (taking NOREPINEPHRINE's "seat"), it creates a negative feedback loop inhibiting the release of fat-burning NOREPINEPHRINE. (healyourselfathome.com)
Sarin1
- The Khamisiyah ammunition storage that housed chemical warfare agents such as sarin, an acetylcholinesterase (AChE) inhibitor, was demolished during the GW, releasing toxicants into the atmosphere affecting deployed troops. (cdc.gov)
Disturbances1
- It seems likely that this neurochemical correlate of positive symptoms might be secondary to disturbances in other neurotransmitter systems. (researchgate.net)
Biological1
- Nuclear-Factor-Kappa Beta, Cox enzymes, Interleukin-1β, MMP-13, and MMP-2, are all biological agents involved in the inflammatory process that can lead to arthritis, cancer, and Alzheimer's disease. (dragoosoilblends.com)
Organs1
- Anticholinergic agents decrease the acid production in the stomach that slows down the natural gut movements, thus relaxing the muscles in several organs such as the stomach, intestines, kidney, and bladder. (rxlist.com)
Medicine1
- Gerry R. Boss, M.D., professor of medicine, has been awarded $3.3 million for pre-clinical and clinical studies of a detoxifying agent for cyanide, a highly toxic compound that could be used as a weapon of mass destruction. (ucsd.edu)
Decrease1
- In an effort to decrease the use of opioids, it is vital for clinicians to first consider other agents to control pain. (netce.com)
Induce3
- Agents that induce pathological changes in the PNS included lead (7439921), chlordecone (143500), and carbon -monoxide (630080). (cdc.gov)
- Quetiapine is a novel antipsychotic agent with many atypical features, including low D(2) and higher 5HT(2A) affinity in vitro, low propensity to induce extra-pyramidal side effects and minimal effects on prolactin levels. (researchgate.net)
- Inhalation of agents in the workplace can induce asthma in a mechanisms involved in asthma. (cdc.gov)
Acute2
- It also includes agents that relieve acute and chronic pain , and others that curb insomnia and facilitate sleep. (psychologytoday.com)
- Eric Liebler, senior vice president of neurology, electroCore, noted in a statement that this marks gammaCore as the only option acute and preventive for both adult and adolescent patients with migraine, which he noted is "represents a unique treatment" for those seeking to avoid the use of prescription pharmaceutical agents. (neurologylive.com)
Mechanism1
- The exact mechanism of inhalational anaesthetic agents is not completely known. (medsci.org)
Evidence1
- Still, evidence to underpin relation between infectious agents and disorientation is insufficient. (cassiopaea.org)
Peripheral1
- CHEMOTHERAPY-INDUCED peripheral neuropathy is a major side effect of many chemotherapeutic agents, including taxanes, platinum-based agents, and vinca alkaloids. (asahq.org)
Bacteria1
- It can act as a drying agent and antibacterial, killing surface bacteria and absorbing oil and dirt. (atavah.com)
Chemical8
- It causes seizures and has been used as a chemical warfare agent. (nih.gov)
- Chemical threats are defined by the NIH as toxic chemical agents that could be used in a terrorist attack against civilians, or those that could be released at toxic levels by accident or natural disaster. (ucsd.edu)
- There are five types of chemical agent banned for use in warfare. (wearethemighty.com)
- Next are blister agents that cause severe chemical burns on the skin and eyes. (wearethemighty.com)
- Research indicates that chemical warfare agents play a key role in the onset and progression of GWI. (cdc.gov)
- Exposure to other chemical agents such as pyridostigmine bromide, N,N-diethyl-m-toluamide, permethrin and chlorpyrifos, were also prevalent during the war. (cdc.gov)
- These additional chemical agents have also been shown to inhibit AChE. (cdc.gov)
- By blocking the enzyme, these agents enhance and prolong the mood-elevating effects of these chemical messengers. (integrativepharmacology.com)
Effects5
- Here we review current knowledge on neurotransmitter-mediated blood-oxygen-level dependent (BOLD) fMRI mechanisms as well as recently updated methodologies aimed at more fully describing the effects of neuropharmacologic agents on the BOLD signal. (umn.edu)
- Agents with sedating effects are widely used to combat insomnia and help people fall asleep or maintain sleep, a major contributor to overall physical and mental health. (psychologytoday.com)
- Both agents have significant side effects and serious limitations in treating large number of victims as they must be either administered intravenously (sodium thiosulfate and sodium nitrate) or inhaled for several minutes (amyl nitrite. (ucsd.edu)
- Effects of calcium and calcium-chelating agents on the inward and outward current in the membrane of mollusc neurones. (wikidata.org)
- It is a natural stimulant without the threatening side effects (palpitations, hyper-activity or rise in blood pressure) of most other stimulating agents. (fasting.ws)
Release3
- [ 32 ] It is a neuromuscular agent that acts presynaptically to block neurotransmitter release and results in muscle weakening. (medscape.com)
- Neurotransmitter is used here in its most general sense, including not only messengers that act directly to regulate ion channels, but also those that act through second messenger systems, and those that act at a distance from their site of release. (nih.gov)
- 1. To identify the structure-activity relationship for causal agents of Date of Original Release: March 2009. (cdc.gov)
Potentially1
- It also helps to remove potentially damaging oxidising agents in a living organism. (globalfoodbook.com)
Therapeutic1
- The Genecept™ Assay is an integrated approach that analyzes neurotransmitter variations to help the clinician arrive at informed therapeutic decisions. (genomind.com)
Tissue1
- Testosterone increases neurotransmitters, which encourage tissue growth. (professionalpickemleague.com)
Depression1
- However, this agent has not yet been tested in patients with severe depression alone. (marcopili.it)
Causative1
- Environmental factors that can detect specific IgE antibodies against most low-molecular- affect the initiation of occupational asthma include the intrinsic weight agents has resulted in a search for alternative or characteristics of causative agents as well as the influence of the complementary physiopathologic mechanisms leading to airway level and route of exposure at the workplace. (cdc.gov)
Infectious agents2
- The authors hypothesize that increased exposure to infectious agents through household crowding might account for this association. (cassiopaea.org)
- In summary infectious agents might influence the cerebral neurotransmitter balance via activating on the tryptophan catabolism. (cassiopaea.org)
Mood2
- So you can see how Kratom acts as a sedative agent to protect our mental health and create an overall mood of happiness and peace. (thebestfashion.co)
- The plant extract also helps normalize neurotransmitters that perform integral roles in mood, memory, and mental health. (atavah.com)
Inflammatory1
- Herein, we evaluated the anti-inflammatory and antioxidant efficacy of diapocynin, an oxidative metabolite of the naturally occurring agent apocynin, in a pre-clinical 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of PD. (springer.com)